Campbell & Co. Investment Adviser »

Blueprint Medicines shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.8M 20k 92.50

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Blueprint Medicines

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Rock Springs Capital Management
State Street Corporation
Jane Street
William Blair Investment Management
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Lord, Abbett & Co
Pictet Asset Management Holding SA
Alliancebernstein
Invesco

View all funds holding Blueprint Medicines